Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multimerin 2 pseudogene (ENSG00000216906) is a processed pseudogene corresponding to the Multimerin 2 (MMRN2) gene. Processed pseudogenes are DNA elements derived from mRNA transcripts that have been reintegrated into the genome by reverse transcription and lack promoters, introns, and generally the ability to code for functional proteins. As such, this locus does not produce a functional protein product and is not considered a functional biological target. Pseudogenes like ENSG00000216906 may occasionally be transcribed into RNA but typically lack significant biological function. This pseudogene is not a receptor, enzyme, or therapeutic target, and does not have direct disease relevance or drug interactions. It should be noted that processed pseudogenes can sometimes complicate genetic analyses due to sequence similarity with their parent genes.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multimerin 2 pseudogene.